Pimstone Simon N.
- SEC CIK
- 0001620084
No open-market purchases or sales filed in the past year.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Directoras of Jun 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pimstone Simon N. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 (view filing) | May 30-Jun 1 | 2 days | Pimstone Simon N.Director | SSale | −131.2K | $38.90 | −$5.10M | −95.6%6.00K after | 7 lots |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Pimstone Simon N.Director | SSale | −19.2K | $36.98 | −$711.2K | −25.9%55.0K after | 2 lots |
| Aug 16, 2022 (view filing) | Aug 12-16 | 4 days | Pimstone Simon N.Director | SSale | −177.1K | $38.25 | −$6.78M | −96.7%6.00K after | 6 lots |
| Mar 8, 2022 (view filing) | Mar 4-8 | 4 days | Pimstone Simon N.Director | SSale | −55.0K | $30.51 | −$1.68M | −22.2%193.1K after | From original15 lots |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Pimstone Simon N.Director | SSale | −17.6K | $31.33 | −$550.1K | −7.7%210.2K after |